Anti-Viral


The virus is composed of a nucleic acid molecule (DNA or RNA) with a protein consisting of non-cell morphology of the campal life of the living body. The general symptoms of viral infection are fever, headache, cough and other symptoms of systemic poisoning and viral host and invasion of tissues and organs leading to inflammatory symptoms caused by local symptoms (diarrhea, rash, liver function damage, etc.). Different symptoms of the different virus, some viruses can also damage the myocardium, causing viral myocarditis. There are two types of viral infections, mostly recessive infections (subclinical infections), and a few are dominant infections. Dominant infection can be divided into acute infection and persistent infection. There are many ways of antiviral infection, such as direct inhibition or killing of viruses, interference with virus adsorption, prevent viruses from penetrating cells, inhibit viral biosynthesis, inhibit viral release or enhance host antivirus capabilities. At present, there are several major types of antiviral drugs: anti-respiratory virus infection drugs, anti-immune virus drugs, anti-hepatitis virus drugs, anti-herpes virus drugs.




CAS 168683-02-1 Peramivir Intermediates 4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2-CYCLOPENTENE-1-CARBOXYLIC ACID METHYL ESTER
CAS 168683-02-1 Peramivir Intermediates 4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2-CYCLOPENTENE-1-CARBOXYLIC ACID METHYL ESTER
151213-42-2,Moxifloxacin Side Chain (S,S)-2,8-Diazabicyclo[4,3,0]nonane
151213-42-2,Moxifloxacin Side Chain (S,S)-2,8-Diazabicyclo[4,3,0]nonane
Cas 61477-40-5,(R)-3-AMINO-1-BUTANOL[Intermediates of Dolutegravir]
Cas 61477-40-5,(R)-3-AMINO-1-BUTANOL[Intermediates of Dolutegravir]
CAS NO.1206102-11-5/Dolutegravir Intermediates:(4R,12aS)-7-(benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-
CAS NO.1206102-11-5/Dolutegravir Intermediates:(4R,12aS)-7-(benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-
CAS 1335210-23-5, High Purity Dolutegravir Intermediates
CAS 1335210-23-5, High Purity Dolutegravir Intermediates
CAS  173676-59-0,4-Chloro-2-(trifluoroacetyl)aniline^hydrochloride hydrate for Making Efavirenz
CAS 173676-59-0,4-Chloro-2-(trifluoroacetyl)aniline^hydrochloride hydrate for Making Efavirenz
CAS 817204-32-3,InterMediate of Sofosbuir
CAS 817204-32-3,InterMediate of Sofosbuir
CAS 863329-66-2,HCV Inhibitor 2'-deoxy-2'-fluoro-2'-C-methyluridine
CAS 863329-66-2,HCV Inhibitor 2'-deoxy-2'-fluoro-2'-C-methyluridine
CAS 1246616-66-9, 4-Oxo-3-(phenylmethoxy)-4H-pyran-2,5-dicarboxylic acid 2,5-dimethyl ester For Dolutegravir Intermediates
CAS 1246616-66-9, 4-Oxo-3-(phenylmethoxy)-4H-pyran-2,5-dicarboxylic acid 2,5-dimethyl ester For Dolutegravir Intermediates
CAS 1616340-68-1,Methyl-5-(2,4-difluorobenzylcarbamoyl)-1-(2,2-dimethoxyethyl)-3-methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate
CAS 1616340-68-1,Methyl-5-(2,4-difluorobenzylcarbamoyl)-1-(2,2-dimethoxyethyl)-3-methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate
CAS 1335210-35-9,Dolutegravir Intermediates
CAS 1335210-35-9,Dolutegravir Intermediates
CAS 198904-85-7, Atazanavir Intermediate Tert-Butyl 2-(4-(pyridin-2-yl)benzyl)hydrazinecarboxylate
CAS 198904-85-7, Atazanavir Intermediate Tert-Butyl 2-(4-(pyridin-2-yl)benzyl)hydrazinecarboxylate
CAS 1256387-74-2,Ledipasvir Intermediate
CAS 1256387-74-2,Ledipasvir Intermediate
Cas 1441670-89-8,Ledipasvir Intermediates
Cas 1441670-89-8,Ledipasvir Intermediates
1335210-23-5, Intermediate of Dolutegravir
1335210-23-5, Intermediate of Dolutegravir
Dolugegravir Intermediate 1335210-23-5
Dolugegravir Intermediate 1335210-23-5
746657-36-3, Intermediate of Simeprevir Cyclopropanecarboxylic Acid
746657-36-3, Intermediate of Simeprevir Cyclopropanecarboxylic Acid
923604-56-2, Simeprevir Intermediates
923604-56-2, Simeprevir Intermediates
923604-57-3, Intermediate of Simeprevir
923604-57-3, Intermediate of Simeprevir
CAS 923604-59-5, Simeprevir Intermediate
CAS 923604-59-5, Simeprevir Intermediate
61477-40-5, Dolutegravir Intermediate
61477-40-5, Dolutegravir Intermediate
1335210-35-9, Dolutegravir Intermediate
1335210-35-9, Dolutegravir Intermediate
3-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid 119736-16-2
3-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid 119736-16-2
DOLUTEGRAVIR N-3 1206102-09-1
DOLUTEGRAVIR N-3 1206102-09-1

© 2019 CHINA WAY. All Rights Reserved.  Taizhou Volsen Chemical Co., Ltd.,  Inc.   All rights reserved. site map.  sitemap.html